M. Mercken
Physiology · 2000–2011
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 50 citations into it
Whom M. Mercken trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Holtzman (in Physiology)
Papers from M. Mercken's perspective
Ordered by how strongly the researchers M. Mercken trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo (Nature Medicine)
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
- APOE Predicts Aβ but not Tau Alzheimer’s Pathology in Cognitively Normal Aging (Annals of Neurology)
- Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease (Proceedings of the National Academy of Sciences of the United States of America)
- Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects (Annals of Neurology)
- Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. (Journal of Clinical Investigation)
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans (Annals of Neurology)
Their papers
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease (2000) — 1,381 citations
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics (2011) — 2,139 citations
- Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease (2005) — 923 citations